Biographical Sketch
Daniel Geisler, MD, FACS, FASCRS, is Associate Staff in the Department of Colorectal Surgery,
specializing in minimally invasive surgery (laparoscopy and transanal endoscopic microsurgery) for disorders of the colon and rectum, with emphasis on sphincter-preservation surgery.
Specialty Interests
carcinoma of the rectum, colon & anus, Colonoscopy, Crohn's Disease, diverticulitis, laparoscopic colorectal surgery, Rectal Prolapse, Sphincter-preservation Surgery, transanal endoscopic microsurgery, Ulcerative Colitis
Innovations & Patents
First single-port colectomy performed in the United States. This was done in conjunction with Dr. Feza Remzi and Dr. Jihad Kaouk and allowed a major abdominal operation (bowel resection) to be performed through a single, small incision (3.5 cm).
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 10/16/2008, Dr.
Geisler has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Geisler receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
US Surgical (Covidien)
